Envoy Medical (NASDAQ:COCH) versus ReWalk Robotics (NASDAQ:LFWD) Critical Analysis

Envoy Medical (NASDAQ:COCH) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership.

Insider and Institutional Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are held by institutional investors. 0.7% of Envoy Medical shares are held by company insiders. Comparatively, 2.1% of ReWalk Robotics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Envoy Medical and ReWalk Robotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	N/A	N/A	-100.39%
ReWalk Robotics	-159.76%	-28.19%	-23.29%

Analyst Recommendations

This is a summary of recent ratings and price targets for Envoy Medical and ReWalk Robotics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
ReWalk Robotics	0	0	1	0	3.00

Envoy Medical currently has a consensus price target of $6.00, indicating a potential upside of 8.50%. ReWalk Robotics has a consensus price target of $9.00, indicating a potential upside of 80.00%. Given ReWalk Robotics’ higher possible upside, analysts clearly believe ReWalk Robotics is more favorable than Envoy Medical.

Risk & Volatility

Envoy Medical has a beta of 2.68, meaning that its share price is 168% more volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500.

Earnings & Valuation

This table compares Envoy Medical and ReWalk Robotics’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	338.71	-$29.91 million	N/A	N/A
ReWalk Robotics	$13.85 million	3.07	-$22.13 million	($2.87)	-1.74

ReWalk Robotics has higher revenue and earnings than Envoy Medical.

Summary

ReWalk Robotics beats Envoy Medical on 6 of the 11 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.